|Articles|December 1, 2018
- Pharmaceutical Executive-12-01-2018
- Volume 38
- Issue 12
Pharmaceutical Executive, December 2018 Issue (PDF)
Click the title above to open the Pharmaceutical December 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Science & Finance: The Biotech Blendalmost 7 years ago
Europe’s Digital Health Path Still at a Crossroadsalmost 7 years ago
Lessons for Pharma from the Merck Cyber Attackalmost 7 years ago
Securing a Winning Strategy for Real-World Evidencealmost 7 years ago
RWE: Answering Questions in Rare Diseasealmost 7 years ago
Measuring the Probability of Pricing and Access Successalmost 7 years ago
Four Challenges for AI in the Life Sciencesalmost 7 years ago
Country Report: MalaysiaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
